72.jpeg)
The country's first messenger mRNA vaccine is expected to begin trials on humans in February.
The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data. Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) is expected to review the data soon, the official sources said. Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon, the official sources said.
Editor In Chief : Dr Dhimant Purohit
Know your world in 60 words - Read News in just 1 minute
Hot Topics
Select the content to hear the Audio
139.jpeg)
260.jpeg)
259.jpeg)
258.jpeg)
